We are live on ! Find out more
ARTA

A.R.T. Advisors Portfolio holdings

AUM $1.79M
1-Year Est. Return 57.47%
This Fund
S&P 500
This Quarter Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
-$296M
Cap. Flow
+$44.6M
Cap. Flow %
1.65%
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$26.9M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$24.9M
3
PARA
Paramount Global Class B
PARA
+$19.8M
4
MS icon
Morgan Stanley
MS
+$18.5M
5
KHC icon
Kraft Heinz
KHC
+$16.7M

Top Sells

Rank Stock Value
1
COR icon
Cencora
COR
+$22.3M
2
AMGN icon
Amgen
AMGN
+$21.9M
3
BABA icon
Alibaba
BABA
+$18.9M
4
SLB icon
SLB Ltd
SLB
+$18M
5
BMY icon
Bristol-Myers Squibb
BMY
+$14.8M

Sector Composition

Rank Sector Weight
1 Healthcare 13.76%
2 Technology 13.33%
3 Consumer Discretionary 12.45%
4 Industrials 11.02%
5 Financials 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DARE icon
1301
Dare Bioscience
DARE
$18M
$42K ﹤0.01%
+96
New +$48.3K
FLNA
1302
Filana Therapeutics
FLNA
$42.3M
$39K ﹤0.01%
3,090
+400
+15% +$5.05K
TURN
1303
DELISTED
180 Degree Capital
TURN
$38K ﹤0.01%
5,936
-1,167
-16% -$8.82K
ACLS icon
1304
Axcelis
ACLS
$3.57B
$32K ﹤0.01%
+3,032
New +$36.9K
PLX icon
1305
Protalix BioTherapeutics
PLX
$188M
$31K ﹤0.01%
2,694
– –
PHLT
1306
DELISTED
Performant Healthcare Inc
PHLT
$28K ﹤0.01%
11,770
-8,082
-41% -$23.5K
TTHI
1307
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$27K ﹤0.01%
+15,119
New +$32.2K
INSG icon
1308
Inseego
INSG
$104M
$25K ﹤0.01%
1,157
-2,783
-71% -$70.9K
MBII
1309
DELISTED
Marrone Bio Innovations, Inc.
MBII
$25K ﹤0.01%
11,861
-11,000
-48% -$21.4K
OCLR
1310
DELISTED
Oclaro Inc.
OCLR
$23K ﹤0.01%
+10,230
New +$25K
NOA
1311
North American Construction
NOA
$367M
$22K ﹤0.01%
10,478
-1,800
-15% -$3.78K
ROX
1312
DELISTED
Castle Brands, Inc.
ROX
$22K ﹤0.01%
17,400
– –
PES
1313
DELISTED
Pioneer Energy Services Corp.
PES
$22K ﹤0.01%
+10,615
New +$36.1K
IMN
1314
DELISTED
Imation
IMN
$22K ﹤0.01%
10,447
-1,300
-11% -$4.33K
GAU
1315
Galiano Gold
GAU
$441M
$21K ﹤0.01%
14,611
-3,854
-21% -$6.17K
AXTI icon
1316
AXT Inc
AXTI
$2.57B
$20K ﹤0.01%
10,555
-200
-2% -$449
GDP
1317
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
$11K ﹤0.01%
19,103
-4,000
-17% -$3.72K
QRHC icon
1318
Quest Resource Holding
QRHC
$28M
$7K ﹤0.01%
1,700
– –
ACIC icon
1319
American Coastal Insurance
ACIC
$526M
– –
-66,366
Closed -$1.03M
ACTG icon
1320
Acacia Research
ACTG
$442M
– –
-139,077
Closed -$1.22M
ADTN icon
1321
Adtran
ADTN
$677M
– –
-39,575
Closed -$643K
AKBA icon
1322
Akebia Therapeutics
AKBA
$335M
– –
-35,375
Closed -$364K
AL
1323
DELISTED
Air Lease Corp
AL
– –
-51,303
Closed -$1.74M
ALB icon
1324
Albemarle
ALB
$13.3B
– –
-11,907
Closed -$658K
ALGN icon
1325
Align Technology
ALGN
$12.8B
– –
-61,897
Closed -$3.88M
51 52
53
54 55

Similar funds

MA
MANA Advisors New York $3.06M AUM 7.13% 1-Year Est. Return
FFIM
Founders Fund III Management San Francisco, California $435K AUM
LC
Lunia Capital Dallas, Texas $4.49M AUM 42.82% 1-Year Est. Return
YEPV
Yorktown Energy Partners VI New York $6.21M AUM 74.4% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM

A.R.T. Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.

A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

  • A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
  • A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
  • A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
  • A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
  • A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
  • A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
  • A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.

Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.